Differences in Cardiometabolic Proteins in Pregnancy Prioritize Relevant Targets of Preeclampsia
子痫前期
怀孕
生物信息学
血压
炎症
产科
生物标志物
内科学
医学
生物
遗传学
生物化学
作者
Kathryn J. Lindley,Andrew Perry,Marni Jacobs,Lauren E. Petty,Kaushik Amancherla,Shilin Zhao,Claire Barker,Víctor G. Dávila‐Román,Sadiya S. Khan,Sarah S. Osmundson,Kahraman Tanrıverdi,Jane E. Freedman,Jennifer E. Below,Ravi V. Shah,Louise C. Laurent
Preeclampsia is a hypertensive disorder of pregnancy characterized by widespread vascular inflammation. It occurs frequently in pregnancy, often without known risk factors, and has high rates of maternal and fetal morbidity and mortality. Identification of biomarkers that predict preeclampsia and its cardiovascular sequelae before clinical onset, or even before pregnancy, is a critical unmet need for the prevention of adverse pregnancy outcomes.